OrganOx achieves one of the UK’s largest medtech exit to date
OrganOx achieves one of the UK’s largest medtech exit to date OrganOx, the Oxford-based medtech company behind pioneering liver perfusion technology that has transformed transplant outcomes worldwide, has been acquired in a deal valued at approximately $1.5 billion. The transaction also delivered BGF’s biggest return to date, generating £175 million

